Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ute Hegenbart

Showing results (41-50 of 237) with videos related to

Pageof 24
Sort By:
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 16, 2021
Guidelines for high dose chemotherapy and stem cell transplantation for systemic AL amyloidosis: EHA-ISA working group guidelinesVaishali Sanchorawala, Mario Boccadoro, Morie Gertz, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 25, 2017
Amyloid in bone marrow smears in systemic light-chain amyloidosisChristoph Kimmich, Stefan Schönland, Sandra Kräker, et al.
Nature Communications|November 22, 2023
Common transthyretin-derived amyloid fibril structures in patients with hereditary ATTR amyloidosisMaximilian Steinebrei, Julian Baur, Anaviggha Pradhan, et al.
Biomarker Research|October 14, 2023
First third-generation CAR T cell application targeting CD19 for the treatment of systemic IgM AL amyloidosis with underlying marginal zone lymphomaFelix Korell, Stefan Schönland, Anita Schmitt, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 30, 2017
Comparison of Different Stem Cell Mobilization Regimens in AL Amyloidosis PatientsKatharina Lisenko, Patrick Wuchter, Marion Hansberg, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 8, 2014
Risk factors for AA amyloidosis in GermanyNorbert Blank, Ute Hegenbart, Peter Lohse, et al.
Virchows Archiv : an International Journal of Pathology|August 24, 2018
Local vs. systemic pulmonary amyloidosis-impact on diagnostics and clinical managementJulius-Valentin Baumgart, Christiane Stuhlmann-Laeisz, Ute Hegenbart, et al.
Haematologica|December 9, 2017
Prognostic significance of tumor burden assessed by whole-body magnetic resonance imaging in multiple myeloma patients treated with allogeneic stem cell transplantationJennifer Mosebach, Sofia Shah, Stefan Delorme, et al.
Haematologica|June 11, 2026
Retrospective cohort study of treatment with BCL-2 inhibitor venetoclax in advanced AL amyloidosisKaya Veelken, Stefan Schönland, Tobias Dittrich, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 8, 2026
The CATCH-ATTR study: CArpal Tunnel ligament amyloid-the Clue for early identification of Hereditary or wildtype systemic ATTR amyloidosis?Fabian Aus dem Siepen, Frank Staub, Florian Andre, et al.
Pageof 24

Showing results (41-50 of 237) with videos related to

Sort By:
Pageof 24
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 16, 2021
Guidelines for high dose chemotherapy and stem cell transplantation for systemic AL amyloidosis: EHA-ISA working group guidelinesVaishali Sanchorawala, Mario Boccadoro, Morie Gertz, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 25, 2017
Amyloid in bone marrow smears in systemic light-chain amyloidosisChristoph Kimmich, Stefan Schönland, Sandra Kräker, et al.
Nature Communications|November 22, 2023
Common transthyretin-derived amyloid fibril structures in patients with hereditary ATTR amyloidosisMaximilian Steinebrei, Julian Baur, Anaviggha Pradhan, et al.
Biomarker Research|October 14, 2023
First third-generation CAR T cell application targeting CD19 for the treatment of systemic IgM AL amyloidosis with underlying marginal zone lymphomaFelix Korell, Stefan Schönland, Anita Schmitt, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 30, 2017
Comparison of Different Stem Cell Mobilization Regimens in AL Amyloidosis PatientsKatharina Lisenko, Patrick Wuchter, Marion Hansberg, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 8, 2014
Risk factors for AA amyloidosis in GermanyNorbert Blank, Ute Hegenbart, Peter Lohse, et al.
Virchows Archiv : an International Journal of Pathology|August 24, 2018
Local vs. systemic pulmonary amyloidosis-impact on diagnostics and clinical managementJulius-Valentin Baumgart, Christiane Stuhlmann-Laeisz, Ute Hegenbart, et al.
Haematologica|December 9, 2017
Prognostic significance of tumor burden assessed by whole-body magnetic resonance imaging in multiple myeloma patients treated with allogeneic stem cell transplantationJennifer Mosebach, Sofia Shah, Stefan Delorme, et al.
Haematologica|June 11, 2026
Retrospective cohort study of treatment with BCL-2 inhibitor venetoclax in advanced AL amyloidosisKaya Veelken, Stefan Schönland, Tobias Dittrich, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 8, 2026
The CATCH-ATTR study: CArpal Tunnel ligament amyloid-the Clue for early identification of Hereditary or wildtype systemic ATTR amyloidosis?Fabian Aus dem Siepen, Frank Staub, Florian Andre, et al.
Pageof 24